An In Silico Multi-epitopes Vaccine Ensemble and Characterization Against Nosocomial Proteus penneri
Proteus penneri ( P. penneri ) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections. P. penneri strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin...
Saved in:
| Published in: | Molecular biotechnology Vol. 66; no. 12; pp. 3498 - 3513 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
New York
Springer US
01.12.2024
Springer Nature B.V |
| Subjects: | |
| ISSN: | 1073-6085, 1559-0305, 1559-0305 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Proteus penneri
(
P. penneri
) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections.
P. penneri
strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin G, and cephalosporins; in addition, no vaccines are available against these strains. This warrants efforts to propose a theoretical based multi-epitope vaccine construct to prevent pathogen infections
.
In this research, reverse vaccinology bioinformatics and immunoinformatics approaches were adopted for vaccine target identification and construction of a multi-epitope vaccine. In the first phase, a core proteome dataset of the targeted pathogen was obtained using the NCBI database and subjected to bacterial pan-genome analysis using bacterial pan-genome analysis (BPGA) to predict core protein sequences which were then used to find good vaccine target candidates. This identified two proteins, Hcp family type VI secretion system effector and superoxide dismutase family protein, as promising vaccine targets. Afterward using the IEDB database, different B-cell and T-cell epitopes were predicted. A set of four epitopes “KGSVNVQDRE, NTGKLTGTR, IIHSDSWNER, and KDGKPVPALK” were chosen for the development of a multi-epitope vaccine construct. A 183 amino acid long vaccine design was built along with “EAAAK” and “GPGPG” linkers and a cholera toxin B-subunit adjuvant. The designed vaccine model comprised immunodominant, non-toxic, non-allergenic, and physicochemical stable epitopes. The model vaccine was docked with MHC-I, MHC-II, and TLR-4 immune cell receptors using the Cluspro2.0 web server. The binding energy score of the vaccine was − 654.7 kcal/mol for MHC-I, − 738.4 kcal/mol for MHC-II, and − 695.0 kcal/mol for TLR-4. A molecular dynamic simulation was done using AMBER v20 package for dynamic behavior in nanoseconds. Additionally, MM-PBSA binding free energy analysis was done to test intermolecular binding interactions between docked molecules. The MM-GBSA net binding energy score was − 148.00 kcal/mol, − 118.00 kcal/mol, and − 127.00 kcal/mol for vaccine with TLR-4, MHC-I, and MHC-II, respectively. Overall, these in silico-based predictions indicated that the vaccine is highly promising in terms of developing protective immunity against
P. penneri
. However, additional experimental validation is required to unveil the real immune response to the designed vaccine. |
|---|---|
| AbstractList | Proteus penneri (P. penneri) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections. P. penneri strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin G, and cephalosporins; in addition, no vaccines are available against these strains. This warrants efforts to propose a theoretical based multi-epitope vaccine construct to prevent pathogen infections. In this research, reverse vaccinology bioinformatics and immunoinformatics approaches were adopted for vaccine target identification and construction of a multi-epitope vaccine. In the first phase, a core proteome dataset of the targeted pathogen was obtained using the NCBI database and subjected to bacterial pan-genome analysis using bacterial pan-genome analysis (BPGA) to predict core protein sequences which were then used to find good vaccine target candidates. This identified two proteins, Hcp family type VI secretion system effector and superoxide dismutase family protein, as promising vaccine targets. Afterward using the IEDB database, different B-cell and T-cell epitopes were predicted. A set of four epitopes “KGSVNVQDRE, NTGKLTGTR, IIHSDSWNER, and KDGKPVPALK” were chosen for the development of a multi-epitope vaccine construct. A 183 amino acid long vaccine design was built along with “EAAAK” and “GPGPG” linkers and a cholera toxin B-subunit adjuvant. The designed vaccine model comprised immunodominant, non-toxic, non-allergenic, and physicochemical stable epitopes. The model vaccine was docked with MHC-I, MHC-II, and TLR-4 immune cell receptors using the Cluspro2.0 web server. The binding energy score of the vaccine was − 654.7 kcal/mol for MHC-I, − 738.4 kcal/mol for MHC-II, and − 695.0 kcal/mol for TLR-4. A molecular dynamic simulation was done using AMBER v20 package for dynamic behavior in nanoseconds. Additionally, MM-PBSA binding free energy analysis was done to test intermolecular binding interactions between docked molecules. The MM-GBSA net binding energy score was − 148.00 kcal/mol, − 118.00 kcal/mol, and − 127.00 kcal/mol for vaccine with TLR-4, MHC-I, and MHC-II, respectively. Overall, these in silico-based predictions indicated that the vaccine is highly promising in terms of developing protective immunity against P. penneri. However, additional experimental validation is required to unveil the real immune response to the designed vaccine. Proteus penneri (P. penneri) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections. P. penneri strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin G, and cephalosporins; in addition, no vaccines are available against these strains. This warrants efforts to propose a theoretical based multi-epitope vaccine construct to prevent pathogen infections. In this research, reverse vaccinology bioinformatics and immunoinformatics approaches were adopted for vaccine target identification and construction of a multi-epitope vaccine. In the first phase, a core proteome dataset of the targeted pathogen was obtained using the NCBI database and subjected to bacterial pan-genome analysis using bacterial pan-genome analysis (BPGA) to predict core protein sequences which were then used to find good vaccine target candidates. This identified two proteins, Hcp family type VI secretion system effector and superoxide dismutase family protein, as promising vaccine targets. Afterward using the IEDB database, different B-cell and T-cell epitopes were predicted. A set of four epitopes "KGSVNVQDRE, NTGKLTGTR, IIHSDSWNER, and KDGKPVPALK" were chosen for the development of a multi-epitope vaccine construct. A 183 amino acid long vaccine design was built along with "EAAAK" and "GPGPG" linkers and a cholera toxin B-subunit adjuvant. The designed vaccine model comprised immunodominant, non-toxic, non-allergenic, and physicochemical stable epitopes. The model vaccine was docked with MHC-I, MHC-II, and TLR-4 immune cell receptors using the Cluspro2.0 web server. The binding energy score of the vaccine was - 654.7 kcal/mol for MHC-I, - 738.4 kcal/mol for MHC-II, and - 695.0 kcal/mol for TLR-4. A molecular dynamic simulation was done using AMBER v20 package for dynamic behavior in nanoseconds. Additionally, MM-PBSA binding free energy analysis was done to test intermolecular binding interactions between docked molecules. The MM-GBSA net binding energy score was - 148.00 kcal/mol, - 118.00 kcal/mol, and - 127.00 kcal/mol for vaccine with TLR-4, MHC-I, and MHC-II, respectively. Overall, these in silico-based predictions indicated that the vaccine is highly promising in terms of developing protective immunity against P. penneri. However, additional experimental validation is required to unveil the real immune response to the designed vaccine. Proteus penneri ( P. penneri ) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections. P. penneri strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin G, and cephalosporins; in addition, no vaccines are available against these strains. This warrants efforts to propose a theoretical based multi-epitope vaccine construct to prevent pathogen infections . In this research, reverse vaccinology bioinformatics and immunoinformatics approaches were adopted for vaccine target identification and construction of a multi-epitope vaccine. In the first phase, a core proteome dataset of the targeted pathogen was obtained using the NCBI database and subjected to bacterial pan-genome analysis using bacterial pan-genome analysis (BPGA) to predict core protein sequences which were then used to find good vaccine target candidates. This identified two proteins, Hcp family type VI secretion system effector and superoxide dismutase family protein, as promising vaccine targets. Afterward using the IEDB database, different B-cell and T-cell epitopes were predicted. A set of four epitopes “KGSVNVQDRE, NTGKLTGTR, IIHSDSWNER, and KDGKPVPALK” were chosen for the development of a multi-epitope vaccine construct. A 183 amino acid long vaccine design was built along with “EAAAK” and “GPGPG” linkers and a cholera toxin B-subunit adjuvant. The designed vaccine model comprised immunodominant, non-toxic, non-allergenic, and physicochemical stable epitopes. The model vaccine was docked with MHC-I, MHC-II, and TLR-4 immune cell receptors using the Cluspro2.0 web server. The binding energy score of the vaccine was − 654.7 kcal/mol for MHC-I, − 738.4 kcal/mol for MHC-II, and − 695.0 kcal/mol for TLR-4. A molecular dynamic simulation was done using AMBER v20 package for dynamic behavior in nanoseconds. Additionally, MM-PBSA binding free energy analysis was done to test intermolecular binding interactions between docked molecules. The MM-GBSA net binding energy score was − 148.00 kcal/mol, − 118.00 kcal/mol, and − 127.00 kcal/mol for vaccine with TLR-4, MHC-I, and MHC-II, respectively. Overall, these in silico-based predictions indicated that the vaccine is highly promising in terms of developing protective immunity against P. penneri . However, additional experimental validation is required to unveil the real immune response to the designed vaccine. Proteus penneri (P. penneri) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections. P. penneri strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin G, and cephalosporins; in addition, no vaccines are available against these strains. This warrants efforts to propose a theoretical based multi-epitope vaccine construct to prevent pathogen infections. In this research, reverse vaccinology bioinformatics and immunoinformatics approaches were adopted for vaccine target identification and construction of a multi-epitope vaccine. In the first phase, a core proteome dataset of the targeted pathogen was obtained using the NCBI database and subjected to bacterial pan-genome analysis using bacterial pan-genome analysis (BPGA) to predict core protein sequences which were then used to find good vaccine target candidates. This identified two proteins, Hcp family type VI secretion system effector and superoxide dismutase family protein, as promising vaccine targets. Afterward using the IEDB database, different B-cell and T-cell epitopes were predicted. A set of four epitopes "KGSVNVQDRE, NTGKLTGTR, IIHSDSWNER, and KDGKPVPALK" were chosen for the development of a multi-epitope vaccine construct. A 183 amino acid long vaccine design was built along with "EAAAK" and "GPGPG" linkers and a cholera toxin B-subunit adjuvant. The designed vaccine model comprised immunodominant, non-toxic, non-allergenic, and physicochemical stable epitopes. The model vaccine was docked with MHC-I, MHC-II, and TLR-4 immune cell receptors using the Cluspro2.0 web server. The binding energy score of the vaccine was - 654.7 kcal/mol for MHC-I, - 738.4 kcal/mol for MHC-II, and - 695.0 kcal/mol for TLR-4. A molecular dynamic simulation was done using AMBER v20 package for dynamic behavior in nanoseconds. Additionally, MM-PBSA binding free energy analysis was done to test intermolecular binding interactions between docked molecules. The MM-GBSA net binding energy score was - 148.00 kcal/mol, - 118.00 kcal/mol, and - 127.00 kcal/mol for vaccine with TLR-4, MHC-I, and MHC-II, respectively. Overall, these in silico-based predictions indicated that the vaccine is highly promising in terms of developing protective immunity against P. penneri. However, additional experimental validation is required to unveil the real immune response to the designed vaccine.Proteus penneri (P. penneri) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological agent of several hospital-associated infections. P. penneri strains are naturally resistant to macrolides, amoxicillin, oxacillin, penicillin G, and cephalosporins; in addition, no vaccines are available against these strains. This warrants efforts to propose a theoretical based multi-epitope vaccine construct to prevent pathogen infections. In this research, reverse vaccinology bioinformatics and immunoinformatics approaches were adopted for vaccine target identification and construction of a multi-epitope vaccine. In the first phase, a core proteome dataset of the targeted pathogen was obtained using the NCBI database and subjected to bacterial pan-genome analysis using bacterial pan-genome analysis (BPGA) to predict core protein sequences which were then used to find good vaccine target candidates. This identified two proteins, Hcp family type VI secretion system effector and superoxide dismutase family protein, as promising vaccine targets. Afterward using the IEDB database, different B-cell and T-cell epitopes were predicted. A set of four epitopes "KGSVNVQDRE, NTGKLTGTR, IIHSDSWNER, and KDGKPVPALK" were chosen for the development of a multi-epitope vaccine construct. A 183 amino acid long vaccine design was built along with "EAAAK" and "GPGPG" linkers and a cholera toxin B-subunit adjuvant. The designed vaccine model comprised immunodominant, non-toxic, non-allergenic, and physicochemical stable epitopes. The model vaccine was docked with MHC-I, MHC-II, and TLR-4 immune cell receptors using the Cluspro2.0 web server. The binding energy score of the vaccine was - 654.7 kcal/mol for MHC-I, - 738.4 kcal/mol for MHC-II, and - 695.0 kcal/mol for TLR-4. A molecular dynamic simulation was done using AMBER v20 package for dynamic behavior in nanoseconds. Additionally, MM-PBSA binding free energy analysis was done to test intermolecular binding interactions between docked molecules. The MM-GBSA net binding energy score was - 148.00 kcal/mol, - 118.00 kcal/mol, and - 127.00 kcal/mol for vaccine with TLR-4, MHC-I, and MHC-II, respectively. Overall, these in silico-based predictions indicated that the vaccine is highly promising in terms of developing protective immunity against P. penneri. However, additional experimental validation is required to unveil the real immune response to the designed vaccine. |
| Author | Hassan, Muhammad Naz, Tahira ul Haq, Mehboob Sanami, Samira Irfan, Muhammad Rehman, Bushra Waheed, Yasir Khan, Saifullah Almanaa, Taghreed N. Muhammad, Riaz Ahmad, Sajjad Ullah, Asad |
| Author_xml | – sequence: 1 givenname: Asad surname: Ullah fullname: Ullah, Asad organization: Department of Health and Biological Sciences, Abasyn University, Centre of Biotechnology and Microbiology, University of Peshawar – sequence: 2 givenname: Bushra surname: Rehman fullname: Rehman, Bushra organization: Institute of Biotechnology and Microbiology, Bacha Khan University – sequence: 3 givenname: Saifullah surname: Khan fullname: Khan, Saifullah organization: Institute of Biotechnology and Microbiology, Bacha Khan University – sequence: 4 givenname: Taghreed N. surname: Almanaa fullname: Almanaa, Taghreed N. organization: Department of Botany and Microbiology, College of Science, King Saud University – sequence: 5 givenname: Yasir surname: Waheed fullname: Waheed, Yasir organization: Office of Research, Innovation and Commercialization, Shaheed Zulfiqar Ali Bhutto Medical University (SZABMU), Gilbert and Rose-Marie Chagoury School of Medicine, Lebanese American University – sequence: 6 givenname: Muhammad surname: Hassan fullname: Hassan, Muhammad organization: Department of Pharmacy, Bacha Khan University – sequence: 7 givenname: Tahira surname: Naz fullname: Naz, Tahira organization: Department of Chemical and Life Sciences, Qurtuba University of Science and Technology – sequence: 8 givenname: Mehboob surname: ul Haq fullname: ul Haq, Mehboob organization: Department of Pharmacy, Abasyn University – sequence: 9 givenname: Riaz surname: Muhammad fullname: Muhammad, Riaz organization: Department of Health and Biological Sciences, Abasyn University – sequence: 10 givenname: Samira surname: Sanami fullname: Sanami, Samira organization: Nervous System Stem Cells Research Center, Semnan University of Medical Sciences – sequence: 11 givenname: Muhammad surname: Irfan fullname: Irfan, Muhammad organization: Department of Oral Biology, College of Dentistry, University of Florida – sequence: 12 givenname: Sajjad orcidid: 0000-0003-0754-1742 surname: Ahmad fullname: Ahmad, Sajjad email: sajjad.ahmad@abasyn.edu.pk organization: Department of Health and Biological Sciences, Abasyn University, Department of Natural Sciences, Lebanese American University |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37934390$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkUtr3TAQhUVJaB7tH-iiCLrpxo2etrS8XJI2kDaBPrZClsepgi25kry4_fVVcxMKWaQLMYL5zmFmzgk6CDEAQm8o-UAJ6c4yZYTzhrD6iBa62b1Ax1RK3RBO5EH9k443LVHyCJ3kfEcIo1Lwl-iId5oLrskxGjYBXwb81U_eRfx5nYpvYPElLpDxD-ucD4DPQ4a5nwDbMODtT5usK5D8b1t8DHhza33IBX-JObo4ezvhmxQLrBkvEEIFX6HD0U4ZXj_UU_T94vzb9lNzdf3xcru5apwgqjSWWqWUVoKqUY4jdH0_WM4GphnrOTihO851LX1b2yPlQIdBDsD4IIkeGT9F7_e-S4q_VsjFzD47mCYbIK7Z8Lo-7Zjq2v-iTKlWC9oqXtF3T9C7uKZQF6mGTAmhCZWVevtArf0Mg1mSn23amcdTV0DtAZdizglG43y5v2BJ1k-GEvM3VbNP1dRUzX2qZlel7In00f1ZEd-LcoXDLaR_Yz-j-gPI1bRT |
| CitedBy_id | crossref_primary_10_1007_s11030_024_11034_0 crossref_primary_10_1186_s12879_024_09775_2 crossref_primary_10_1038_s41598_024_84823_0 crossref_primary_10_1007_s11030_025_11108_7 crossref_primary_10_1007_s12013_024_01407_5 crossref_primary_10_24171_j_phrp_2024_0349 crossref_primary_10_1007_s40203_024_00271_8 crossref_primary_10_1186_s12879_024_10272_9 crossref_primary_10_1186_s12896_024_00873_2 crossref_primary_10_1371_journal_pone_0324453 crossref_primary_10_1155_jimr_6348238 crossref_primary_10_1186_s12879_025_11242_5 crossref_primary_10_24171_j_phrp_2024_0026 crossref_primary_10_3390_medicina60101632 crossref_primary_10_3389_fimmu_2024_1426496 crossref_primary_10_1007_s00894_025_06301_2 crossref_primary_10_1038_s41598_025_87063_y crossref_primary_10_1186_s12985_024_02440_9 crossref_primary_10_1038_s41598_025_90226_6 crossref_primary_10_1177_11779322251324859 crossref_primary_10_1371_journal_pone_0318523 crossref_primary_10_1371_journal_pone_0317520 |
| Cites_doi | 10.1001/jama.276.22.1793 10.1016/j.ejps.2020.105258 10.1111/j.1399-0039.2004.00302.x 10.1007/s00894-014-2278-5 10.3390/vaccines11020263 10.1016/j.compbiomed.2021.104705 10.3390/ijerph19148408 10.3390/vaccines10081192 10.1021/ct400340s 10.1021/jacsau.2c00532 10.3390/vaccines10050665 10.1080/07391102.2022.2153920 10.3389/fimmu.2022.1035924 10.1016/j.molliq.2009.01.009 10.1038/srep24373 10.1002/prot.20050 10.1126/science.1109869 10.1080/21645515.2018.1476814 10.3390/biom11081072 10.1093/bioinformatics/btl158 10.1021/ci100275a 10.1128/JVI.01155-16 10.3389/fimmu.2022.998262 10.3390/vaccines10030462 10.3390/ijerph182010961 10.1093/nar/gkl971 10.1038/s41598-021-90868-2 10.1093/femsre/fux016 10.3389/fmicb.2020.00256 10.4103/amhsr.amhsr_413_15 10.1002/jcc.21787 10.1186/1471-2105-14-S19-S1 10.1016/j.str.2020.06.006 10.1002/pro.4473 10.1016/S0264-410X(02)00566-2 10.3390/ijerph19063729 10.1111/cei.13292 10.1093/nar/gkv1271 10.1093/nar/gki396 10.3390/ijerph19095568 10.1016/j.vaccine.2017.06.003 10.3389/fmicb.2015.00392 10.6026/97320630006255 10.1007/s00248-015-0720-6 10.1093/nar/gku938 10.1016/j.amjms.2020.06.028 10.1007/978-1-61779-588-6_10 10.3390/vaccines10020189 10.1371/journal.pone.0286224 10.1093/nar/gkab279 10.1016/j.ejps.2020.105387 10.3390/ijerph19137723 10.1007/s00335-003-2296-6 10.1093/nar/gky1006 10.1093/nar/gkl842 10.3389/fimmu.2022.1042997 10.1016/j.jaci.2009.12.980 10.1007/978-1-59745-177-2_4 10.1016/j.drudis.2020.03.006 10.3390/vaccines10111886 10.3390/vaccines10101729 10.1016/S0959-440X(02)00308-1 10.1038/s41598-021-96863-x 10.3390/pathogens10101310 10.3390/vaccines10050691 10.1038/cmi.2017.92 10.1016/j.ygeno.2020.06.026 |
| ContentType | Journal Article |
| Copyright | The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| Copyright_xml | – notice: The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| DBID | AAYXX CITATION NPM 3V. 7QL 7QO 7T7 7U9 7X7 7XB 88A 88E 88I 8AO 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. L6V LK8 M0S M1P M2P M7N M7P M7S P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS Q9U 7X8 7S9 L.6 |
| DOI | 10.1007/s12033-023-00949-y |
| DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Industrial and Applied Microbiology Abstracts (Microbiology A) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Materials Science & Engineering Collection ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest SciTech Premium Collection Natural Science Collection Biological Science Collection ProQuest Central Technology Collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Engineering Collection Biological Sciences ProQuest Health & Medical Collection Medical Database Science Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering Collection ProQuest Central Basic MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitle | CrossRef PubMed ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection Industrial and Applied Microbiology Abstracts (Microbiology A) ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Engineering Database Virology and AIDS Abstracts ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Central Basic ProQuest Science Journals ProQuest SciTech Collection ProQuest Medical Library Materials Science & Engineering Collection ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
| DatabaseTitleList | ProQuest Central Student AGRICOLA PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Engineering Chemistry Biology |
| EISSN | 1559-0305 |
| EndPage | 3513 |
| ExternalDocumentID | 37934390 10_1007_s12033_023_00949_y |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: Deanship of Scientific Research, King Saud University grantid: RSPD2023R632 funderid: http://dx.doi.org/10.13039/501100011665 – fundername: Deanship of Scientific Research, King Saud University grantid: RSPD2023R632 |
| GroupedDBID | --- -Y2 .86 .VR 06C 06D 0R~ 0VY 123 1N0 2.D 203 28- 29M 2J2 2JN 2JY 2KG 2KM 2LR 2VQ 2~H 30V 3SX 4.4 406 408 40D 40E 53G 5VS 67N 6NX 7X7 88E 88I 8AO 8FE 8FG 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X A8Z AAAVM AABHQ AACDK AAHBH AAHNG AAIAL AAIKT AAJBT AAJKR AANXM AANZL AAPKM AARHV AARTL AASML AATNV AATVU AAUYE AAWCG AAYIU AAYQN AAYTO AAYZH ABAKF ABBRH ABDBE ABDZT ABECU ABFSG ABFTV ABHLI ABHQN ABJCF ABJNI ABJOX ABKCH ABMNI ABMQK ABNWP ABQBU ABQSL ABRTQ ABSXP ABTEG ABTHY ABTKH ABTMW ABUWG ABWNU ABXPI ACAOD ACBXY ACCUX ACDTI ACGFS ACGOD ACHSB ACHXU ACIWK ACKNC ACMDZ ACMLO ACOKC ACOMO ACPIV ACPRK ACSTC ACZOJ ADBBV ADHHG ADHIR ADHKG ADKNI ADKPE ADMLS ADRFC ADTPH ADURQ ADYFF ADZKW AEBTG AEFQL AEGAL AEGNC AEJHL AEJRE AEKMD AEMSY AENEX AEOHA AEPYU AESKC AETLH AEUYN AEVLU AEXYK AEZWR AFBBN AFDZB AFEXP AFGCZ AFHIU AFKRA AFLOW AFOHR AFQWF AFRAH AFWTZ AFZKB AGAYW AGDGC AGGDS AGJBK AGMZJ AGQEE AGQMX AGQPQ AGRTI AGWIL AGWZB AGYKE AHAVH AHBYD AHKAY AHMBA AHPBZ AHSBF AHWEU AIAKS AIGIU AIIXL AILAN AITGF AIXLP AJBLW AJRNO AJZVZ ALIPV ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG ATHPR AVWKF AXYYD AYFIA AYJHY AZFZN AZQEC B-. BA0 BBNVY BBWZM BDATZ BENPR BGLVJ BGNMA BHPHI BPHCQ BVXVI CAG CCPQU COF CS3 CSCUP DDRTE DNIVK DPUIP DU5 DWQXO EBD EBLON EBS EIOEI EJD EMOBN ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNUQQ GNWQR GQ7 H13 HCIFZ HF~ HG6 HMCUK HMJXF HRMNR HVGLF HZ~ I-F IJ- IKXTQ ITM IWAJR IZQ I~X I~Z J-C J0Z JBSCW JZLTJ KOV L6V LK8 LLZTM M1P M2P M4Y M7P M7S MA- ML0 N2Q NB0 NDZJH NF0 NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OVD P19 P2P PF0 PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PT4 PT5 PTHSS Q2X QOK QOR QOS R4E R89 R9I RHV RIG RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S3A S3B SAP SBL SCG SCLPG SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW STPWE SV3 SZN T13 T16 TEORI TSG TSV TUC TUS U2A U9L UG4 UKHRP UOJIU UTJUX UZXMN VC2 VFIZW W48 WK6 WK8 YLTOR ZMTXR ~EX ~KM AAYXX AFFHD CITATION NPM 3V. 7QL 7QO 7T7 7U9 7XB 88A 8FD 8FK C1K FR3 H94 K9. M7N P64 PKEHL PQEST PQUKI PRINS Q9U 7X8 7S9 L.6 |
| ID | FETCH-LOGICAL-c408t-a1a88898418f5ffe7bbda32d2922b3ec497339c49b65fff13e1dd5de23d509f23 |
| IEDL.DBID | RSV |
| ISICitedReferencesCount | 34 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001100398000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1073-6085 1559-0305 |
| IngestDate | Fri Sep 05 13:38:13 EDT 2025 Thu Sep 04 16:56:31 EDT 2025 Tue Dec 02 05:41:35 EST 2025 Mon Jul 21 05:39:09 EDT 2025 Tue Nov 18 22:18:51 EST 2025 Sat Nov 29 06:18:00 EST 2025 Mon Jul 21 06:23:03 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 12 |
| Keywords | Bacterial pan-genome analysis Molecular dynamic simulation Multi-epitope vaccine Cholera toxin B-subunit Proteus penneri |
| Language | English |
| License | 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c408t-a1a88898418f5ffe7bbda32d2922b3ec497339c49b65fff13e1dd5de23d509f23 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ORCID | 0000-0003-0754-1742 |
| PMID | 37934390 |
| PQID | 3128449015 |
| PQPubID | 55363 |
| PageCount | 16 |
| ParticipantIDs | proquest_miscellaneous_3154172876 proquest_miscellaneous_2886941683 proquest_journals_3128449015 pubmed_primary_37934390 crossref_citationtrail_10_1007_s12033_023_00949_y crossref_primary_10_1007_s12033_023_00949_y springer_journals_10_1007_s12033_023_00949_y |
| PublicationCentury | 2000 |
| PublicationDate | 20241200 |
| PublicationDateYYYYMMDD | 2024-12-01 |
| PublicationDate_xml | – month: 12 year: 2024 text: 20241200 |
| PublicationDecade | 2020 |
| PublicationPlace | New York |
| PublicationPlace_xml | – name: New York – name: Switzerland – name: Totowa |
| PublicationTitle | Molecular biotechnology |
| PublicationTitleAbbrev | Mol Biotechnol |
| PublicationTitleAlternate | Mol Biotechnol |
| PublicationYear | 2024 |
| Publisher | Springer US Springer Nature B.V |
| Publisher_xml | – name: Springer US – name: Springer Nature B.V |
| References | Jespersen, Peters, Nielsen, Marcatili (CR45) 2017 Davin-Regli, Pagès (CR7) 2015; 6 Sánchez-Aparicio, Ayllon, Leo-Macias, Wolff, García-Sastre (CR70) 2017; 91 Peabody, Laird, Vlasschaert, Lo, Brinkman (CR36) 2016; 44 CR38 Yousaf, Ismail, Ullah, Bibi (CR52) 2022; 13 Mezei, Fleming, Srinivasan, Rose (CR58) 2004; 55 Jansen, Anderson (CR32) 2018; 14 Banin, Hughes, Kuipers (CR5) 2017; 41 CR30 CR73 CR72 CR71 Ventola (CR6) 2015; 40 Chen, Li, Song, Yang (CR59) 2009; 146 Pal, Hooja, Sharma, Maheshwari (CR21) 2016; 6 Rapin, Lund, Bernaschi, Castiglione (CR64) 2010; 5 Buynak, Roehm, Tytell (CR16) 1996; 276 Craig, Dombkowski (CR51) 2013; 14 Chaudhari, Gupta, Dutta (CR34) 2016; 6 Li, Wu, Huang, Hu, Zhang, Yang, Yang (CR3) 2023; 102 Blast (CR41) 2015 Ismail, Ahmad, Azam (CR31) 2020; 146 CR48 CR47 CR46 CR44 CR43 Cheng, Randall, Sweredoski, Baldi (CR49) 2005; 33 Chen, Yu, Luo, Jiang (CR37) 2003; 14 CR42 Rahman, Ajmal, Ali, Rastrelli (CR67) 2020; 112 Adu-Bobie, Capecchi, Serruto, Rappuoli, Pizza (CR15) 2003; 21 CR40 Hansson, Oostenbrink, van Gunsteren (CR55) 2002; 12 Drzewiecka (CR8) 2016; 72 Attar (CR74) 2023; 84 Hou, Wang, Li, Wang (CR62) 2011; 51 Misra, Panda, Shah, Sukla, Chaubey (CR77) 2011; 6 Pizza, Grandi, Telford, Rappuoli (CR14) 2002; 20 Dimitrov, Bangov, Flower, Doytchinova (CR39) 2014; 20 Cid, Bolívar (CR12) 2021; 11 Girlich, Bonnin, Dortet, Naas (CR9) 2020; 11 Zhang (CR19) 2018; 15 CR18 CR17 Laskowski (CR50) 2022; 31 CR57 Stolfi, Castiglione, Mastrostefano, Di Biase, Di Biase, Palmieri, Prisco (CR65) 2022; 13 Plotkin, Robinson, Cunningham, Iqbal, Larsen (CR11) 2017; 35 Sharpe, Bowyer, Brackenridge, Lambe (CR66) 2019; 196 Suleman, Rashid, Ali, Sher, Luo, Xie, Xie (CR76) 2022; 13 Parvizpour, Pourseif, Razmara, Rafi, Omidi (CR13) 2020; 25 Mancuso, Midiri, Gerace, Biondo (CR1) 2021; 10 Hall, Wodi, Hamborsky, Morelli, Schillie (CR10) 2021 Li, Godzik (CR35) 2006; 22 Pruitt, Tatusova, Maglott (CR68) 2007; 35 CR29 CR28 CR27 Kaus, Pierce, Walker, McCammon (CR56) 2013; 9 CR26 CR25 Cruz-Lopez, Villarreal-Trevino, Camacho-Ortiz, Morfin-Otero, Flores-Trevino, Garza-Gonzalez (CR4) 2020; 360 CR24 Mangat, Rani, Pathak, Yadav, Utreja, Chhuneja, Chhuneja (CR75) 2022; 17 CR23 CR22 CR20 Michaud-Agrawal, Denning, Woolf, Beckstein (CR61) 2011; 32 Desta, Porter, Xia, Kozakov, Vajda (CR54) 2020; 28 CR63 Pruitt, Tatusova, Maglott (CR33) 2005; 33 Berman, Henrick, Nakamura, Markley (CR53) 2007; 35 CR60 Si, Pethe, Chan-Park (CR2) 2023; 3 Farjadian, Naruse, Kawata, Ghaderi, Bahram, Inoko (CR78) 2004; 64 Chaplin (CR69) 2010; 125 R Cid (949_CR12) 2021; 11 CL Ventola (949_CR6) 2015; 40 KU Jansen (949_CR32) 2018; 14 A Davin-Regli (949_CR7) 2015; 6 E Hall (949_CR10) 2021 S Plotkin (949_CR11) 2017; 35 DD Chaplin (949_CR69) 2010; 125 949_CR63 L Zhang (949_CR19) 2018; 15 949_CR20 949_CR60 KD Pruitt (949_CR68) 2007; 35 949_CR27 949_CR26 949_CR29 949_CR28 949_CR23 MA Peabody (949_CR36) 2016; 44 IT Desta (949_CR54) 2020; 28 N Rapin (949_CR64) 2010; 5 HK Mangat (949_CR75) 2022; 17 949_CR22 MT Sánchez-Aparicio (949_CR70) 2017; 91 949_CR25 949_CR24 EB Buynak (949_CR16) 1996; 276 G Mancuso (949_CR1) 2021; 10 Y Chen (949_CR37) 2003; 14 J Cheng (949_CR49) 2005; 33 T Hou (949_CR62) 2011; 51 M Pizza (949_CR14) 2002; 20 Z Si (949_CR2) 2023; 3 949_CR30 DB Craig (949_CR51) 2013; 14 949_CR73 949_CR72 949_CR71 949_CR38 M Mezei (949_CR58) 2004; 55 E Banin (949_CR5) 2017; 41 JW Kaus (949_CR56) 2013; 9 R-J Li (949_CR3) 2023; 102 S Farjadian (949_CR78) 2004; 64 949_CR40 949_CR43 949_CR42 MC Jespersen (949_CR45) 2017 H Berman (949_CR53) 2007; 35 C Chen (949_CR59) 2009; 146 M Suleman (949_CR76) 2022; 13 N Pal (949_CR21) 2016; 6 D Drzewiecka (949_CR8) 2016; 72 949_CR48 949_CR44 D Girlich (949_CR9) 2020; 11 949_CR47 T Hansson (949_CR55) 2002; 12 N Michaud-Agrawal (949_CR61) 2011; 32 949_CR46 N Rahman (949_CR67) 2020; 112 N Misra (949_CR77) 2011; 6 KD Pruitt (949_CR33) 2005; 33 N Blast (949_CR41) 2015 NM Chaudhari (949_CR34) 2016; 6 R Attar (949_CR74) 2023; 84 P Stolfi (949_CR65) 2022; 13 RA Laskowski (949_CR50) 2022; 31 M Yousaf (949_CR52) 2022; 13 F Cruz-Lopez (949_CR4) 2020; 360 I Dimitrov (949_CR39) 2014; 20 949_CR18 949_CR17 S Ismail (949_CR31) 2020; 146 949_CR57 HR Sharpe (949_CR66) 2019; 196 J Adu-Bobie (949_CR15) 2003; 21 W Li (949_CR35) 2006; 22 S Parvizpour (949_CR13) 2020; 25 |
| References_xml | – ident: CR22 – volume: 55 start-page: 502 issue: 3 year: 2004 end-page: 507 ident: CR58 article-title: Polyproline II helix is the preferred conformation for unfolded polyalanine in water publication-title: Proteins: Structure, Function, and Bioinformatics – volume: 25 start-page: 1034 issue: 6 year: 2020 end-page: 1042 ident: CR13 article-title: Epitope-based vaccine design: A comprehensive overview of bioinformatics approaches publication-title: Drug Discovery Today – volume: 15 start-page: 182 issue: 2 year: 2018 end-page: 184 ident: CR19 article-title: Multi-epitope vaccines: A promising strategy against tumors and viral infections publication-title: Cellular and Molecular Immunology – volume: 360 start-page: 631 issue: 6 year: 2020 end-page: 640 ident: CR4 article-title: Acquired genetic elements that contribute to antimicrobial resistance in frequent Gram-negative causative agents of healthcare-associated infections publication-title: The American Journal of the Medical Sciences – volume: 6 start-page: 267 issue: 5 year: 2016 end-page: 279 ident: CR21 article-title: Phenotypic detection and antibiogram of β-lactamase-producing species in a tertiary care Hospital, India publication-title: Annals of Medical and Health Sciences Research – volume: 11 start-page: 256 year: 2020 ident: CR9 article-title: Genetics of acquired antibiotic resistance genes in spp publication-title: Frontiers in Microbiology – start-page: W24 year: 2017 end-page: W29 ident: CR45 article-title: BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes publication-title: Nucleic acids research – volume: 33 start-page: W72 issue: suppl 2 year: 2005 end-page: W76 ident: CR49 article-title: SCRATCH: A protein structure and structural feature prediction server publication-title: Nucleic Acids Research – ident: CR29 – ident: CR25 – year: 2015 ident: CR41 publication-title: Basic local alignment search tool – volume: 14 start-page: 2142 issue: 9 year: 2018 end-page: 2149 ident: CR32 article-title: The role of vaccines in fighting antimicrobial resistance (AMR) publication-title: Human Vaccines and Immunotherapeutics – ident: CR42 – volume: 276 start-page: 1793 issue: 22 year: 1996 end-page: 1795 ident: CR16 article-title: Vaccine against human hepatitis B publication-title: Journal of the American Medical Association doi: 10.1001/jama.276.22.1793 – ident: CR46 – ident: CR71 – year: 2021 ident: CR10 publication-title: Epidemiology and prevention of vaccine-preventable diseases – volume: 146 start-page: 23 issue: 1–2 year: 2009 end-page: 28 ident: CR59 article-title: Hydrogen bonding analysis of glycerol aqueous solutions: A molecular dynamics simulation study publication-title: Journal of Molecular Liquids – volume: 112 start-page: 3473 issue: 5 year: 2020 end-page: 3483 ident: CR67 article-title: Core proteome mediated therapeutic target mining and multi-epitope vaccine design for publication-title: Genomics – volume: 21 start-page: 605 issue: 7–8 year: 2003 end-page: 610 ident: CR15 article-title: Two years into reverse vaccinology publication-title: Vaccine – volume: 3 start-page: 276 issue: 2 year: 2023 end-page: 292 ident: CR2 article-title: Chemical basis of combination therapy to combat antibiotic resistance publication-title: JACS Au – volume: 14 start-page: 859 issue: 12 year: 2003 end-page: 865 ident: CR37 article-title: Secreted protein prediction system combining CJ-SPHMM, TMHMM, and PSORT publication-title: Mammalian Genome – volume: 13 year: 2022 ident: CR65 article-title: In-silico evaluation of adenoviral COVID-19 vaccination protocols: Assessment of immunological memory up to 6 months after the third dose publication-title: Frontiers in Immunology – volume: 44 start-page: D663 issue: D1 year: 2016 end-page: D668 ident: CR36 article-title: PSORTdb: Expanding the bacteria and archaea protein subcellular localization database to better reflect diversity in cell envelope structures publication-title: Nucleic Acids Research – volume: 13 year: 2022 ident: CR76 article-title: Immunoinformatic-based design of immune-boosting multiepitope subunit vaccines against monkeypox virus and validation through molecular dynamics and immune simulation publication-title: Frontiers in Immunology – volume: 35 start-page: D301 issue: suppl 1 year: 2007 end-page: D303 ident: CR53 article-title: The worldwide Protein Data Bank (wwPDB): Ensuring a single, uniform archive of PDB data publication-title: Nucleic Acids Research – ident: CR57 – volume: 84 year: 2023 ident: CR74 article-title: Integrated computational approaches assisted development of a novel multi-epitope vaccine against MDR publication-title: Brazilian Journal of Biology – ident: CR60 – volume: 32 start-page: 2319 issue: 10 year: 2011 end-page: 2327 ident: CR61 article-title: MDAnalysis: A toolkit for the analysis of molecular dynamics simulations publication-title: Journal of Computational Chemistry – volume: 17 issue: 1 year: 2022 ident: CR75 article-title: Virtual screening, molecular dynamics and binding energy-MM-PBSA studies of natural compounds to identify potential EcR inhibitors against Gennadius publication-title: PLoS One – volume: 28 start-page: 1071 issue: 9 year: 2020 end-page: 1081 ident: CR54 article-title: Performance and its limits in rigid body protein-protein dockACing publication-title: Structure – ident: CR26 – volume: 146 year: 2020 ident: CR31 article-title: Vaccinomics to design a novel single chimeric subunit vaccine for broad-spectrum immunological applications targeting nosocomial Enterobacteriaceae pathogens publication-title: European Journal of Pharmaceutical Sciences doi: 10.1016/j.ejps.2020.105258 – volume: 35 start-page: D61 issue: suppl 1 year: 2007 end-page: D65 ident: CR68 article-title: NCBI reference sequences (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins publication-title: Nucleic Acids Research – volume: 51 start-page: 69 issue: 1 year: 2011 end-page: 82 ident: CR62 article-title: Assessing the performance of the MM/PBSA and MM/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations publication-title: Journal of Chemical Information and Modeling – ident: CR18 – ident: CR43 – volume: 35 start-page: 4064 issue: 33 year: 2017 end-page: 4071 ident: CR11 article-title: The complexity and cost of vaccine manufacturing—An overview publication-title: Vaccine – ident: CR47 – ident: CR72 – volume: 12 start-page: 190 issue: 2 year: 2002 end-page: 196 ident: CR55 article-title: Molecular dynamics simulations publication-title: Current Opinion in Structural Biology – volume: 31 issue: 12 year: 2022 ident: CR50 article-title: PDBsum 1: A standalone program for generating PDBsum analyses publication-title: Protein Science – volume: 20 start-page: 32 issue: 7–8 year: 2002 end-page: 36 ident: CR14 article-title: Reverse vaccinology: A genome-based approach to vaccine development publication-title: Chimica Oggi – ident: CR30 – volume: 5 issue: 4 year: 2010 ident: CR64 article-title: Computational immunology meets bioinformatics: The use of prediction tools for molecular binding in the simulation of the immune system publication-title: PLoS One – volume: 20 start-page: 2278 issue: 6 year: 2014 ident: CR39 article-title: AllerTOP v.2—A server for in silico prediction of allergens publication-title: Journal of Molecular Modeling – volume: 6 start-page: 255 issue: 7 year: 2011 ident: CR77 article-title: Population coverage analysis of T-Cell epitopes of serogroup B from Iron acquisition proteins for vaccine design publication-title: Bioinformation – volume: 40 start-page: 277 issue: 4 year: 2015 ident: CR6 article-title: The antibiotic resistance crisis: Part 1: Causes and threats publication-title: Pharmacy and Therapeutics – volume: 6 start-page: 1 issue: 1 year: 2016 end-page: 10 ident: CR34 article-title: BPGA—An ultra-fast pan-genome analysis pipeline publication-title: Scientific Reports – volume: 9 start-page: 4131 issue: 9 year: 2013 end-page: 4139 ident: CR56 article-title: Improving the efficiency of free energy calculations in the amber molecular dynamics package publication-title: Journal of Chemical Theory and Computation – ident: CR40 – volume: 13 year: 2022 ident: CR52 article-title: Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine publication-title: Frontiers in Immunology – ident: CR63 – ident: CR27 – volume: 64 start-page: 581 issue: 5 year: 2004 end-page: 587 ident: CR78 article-title: Molecular analysis of HLA allele frequencies and haplotypes in Baloch of Iran compared with related populations of Pakistan publication-title: Tissue Antigens – volume: 125 start-page: S3 issue: 2 year: 2010 end-page: S23 ident: CR69 article-title: Overview of the immune response publication-title: Journal of Allergy and Clinical Immunology – ident: CR23 – volume: 33 start-page: D501 issue: suppl 1 year: 2005 end-page: D504 ident: CR33 article-title: NCBI Reference Sequence (RefSeq): A curated non-redundant sequence database of genomes, transcripts and proteins publication-title: Nucleic Acids Research – volume: 196 start-page: 167 issue: 2 year: 2019 end-page: 177 ident: CR66 article-title: HLA-E: Exploiting pathogen-host interactions for vaccine development publication-title: Clinical and Experimental Immunology – ident: CR44 – volume: 11 start-page: 1072 issue: 8 year: 2021 ident: CR12 article-title: Platforms for production of protein-based vaccines: From classical to next-generation strategies publication-title: Biomolecules – ident: CR48 – ident: CR73 – ident: CR38 – ident: CR17 – volume: 91 start-page: 10 issue: 2 year: 2017 end-page: 1128 ident: CR70 article-title: Subcellular localizations of RIG-I, TRIM25, and MAVS complexes publication-title: Journal of Virology – volume: 14 start-page: 1 issue: 1 year: 2013 end-page: 7 ident: CR51 article-title: Disulfide by Design 2.0: A web-based tool for disulfide engineering in proteins publication-title: BMC Bioinformatics – volume: 6 start-page: 392 year: 2015 ident: CR7 article-title: Enterobacter aerogenes and ; versatile bacterial pathogens confronting antibiotic treatment publication-title: Frontiers in Microbiology – volume: 41 start-page: 450 issue: 3 year: 2017 end-page: 452 ident: CR5 article-title: Bacterial pathogens, antibiotics and antibiotic resistance publication-title: FEMS Microbiology Reviews – volume: 102 issue: 31 year: 2023 ident: CR3 article-title: A prospective surveillance study of healthcare-associated infections in an intensive care unit from a tertiary care teaching hospital from 2012–2019 publication-title: Medicine – volume: 72 start-page: 741 year: 2016 end-page: 758 ident: CR8 article-title: Significance and roles of spp. bacteria in natural environments publication-title: Microbial Ecology – volume: 10 start-page: 1310 issue: 10 year: 2021 ident: CR1 article-title: Bacterial antibiotic resistance: The most critical pathogens publication-title: Pathogens – ident: CR28 – ident: CR24 – volume: 22 start-page: 1658 issue: 13 year: 2006 end-page: 1659 ident: CR35 article-title: Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences publication-title: Bioinformatics – ident: CR20 – volume: 64 start-page: 581 issue: 5 year: 2004 ident: 949_CR78 publication-title: Tissue Antigens doi: 10.1111/j.1399-0039.2004.00302.x – volume: 20 start-page: 2278 issue: 6 year: 2014 ident: 949_CR39 publication-title: Journal of Molecular Modeling doi: 10.1007/s00894-014-2278-5 – volume: 276 start-page: 1793 issue: 22 year: 1996 ident: 949_CR16 publication-title: Journal of the American Medical Association doi: 10.1001/jama.276.22.1793 – ident: 949_CR17 doi: 10.3390/vaccines11020263 – ident: 949_CR44 doi: 10.1016/j.compbiomed.2021.104705 – volume: 102 issue: 31 year: 2023 ident: 949_CR3 publication-title: Medicine – ident: 949_CR23 doi: 10.3390/ijerph19148408 – ident: 949_CR18 doi: 10.3390/vaccines10081192 – volume: 9 start-page: 4131 issue: 9 year: 2013 ident: 949_CR56 publication-title: Journal of Chemical Theory and Computation doi: 10.1021/ct400340s – volume: 3 start-page: 276 issue: 2 year: 2023 ident: 949_CR2 publication-title: JACS Au doi: 10.1021/jacsau.2c00532 – ident: 949_CR30 doi: 10.3390/vaccines10050665 – ident: 949_CR25 doi: 10.1080/07391102.2022.2153920 – volume: 13 year: 2022 ident: 949_CR52 publication-title: Frontiers in Immunology doi: 10.3389/fimmu.2022.1035924 – volume: 146 start-page: 23 issue: 1–2 year: 2009 ident: 949_CR59 publication-title: Journal of Molecular Liquids doi: 10.1016/j.molliq.2009.01.009 – volume: 6 start-page: 1 issue: 1 year: 2016 ident: 949_CR34 publication-title: Scientific Reports doi: 10.1038/srep24373 – volume: 55 start-page: 502 issue: 3 year: 2004 ident: 949_CR58 publication-title: Proteins: Structure, Function, and Bioinformatics doi: 10.1002/prot.20050 – ident: 949_CR20 doi: 10.1126/science.1109869 – volume: 14 start-page: 2142 issue: 9 year: 2018 ident: 949_CR32 publication-title: Human Vaccines and Immunotherapeutics doi: 10.1080/21645515.2018.1476814 – volume-title: Epidemiology and prevention of vaccine-preventable diseases year: 2021 ident: 949_CR10 – volume: 11 start-page: 1072 issue: 8 year: 2021 ident: 949_CR12 publication-title: Biomolecules doi: 10.3390/biom11081072 – volume: 22 start-page: 1658 issue: 13 year: 2006 ident: 949_CR35 publication-title: Bioinformatics doi: 10.1093/bioinformatics/btl158 – volume: 51 start-page: 69 issue: 1 year: 2011 ident: 949_CR62 publication-title: Journal of Chemical Information and Modeling doi: 10.1021/ci100275a – volume: 91 start-page: 10 issue: 2 year: 2017 ident: 949_CR70 publication-title: Journal of Virology doi: 10.1128/JVI.01155-16 – volume: 13 year: 2022 ident: 949_CR65 publication-title: Frontiers in Immunology doi: 10.3389/fimmu.2022.998262 – volume: 40 start-page: 277 issue: 4 year: 2015 ident: 949_CR6 publication-title: Pharmacy and Therapeutics – ident: 949_CR72 doi: 10.3390/vaccines10030462 – ident: 949_CR22 doi: 10.3390/ijerph182010961 – volume: 35 start-page: D301 issue: suppl 1 year: 2007 ident: 949_CR53 publication-title: Nucleic Acids Research doi: 10.1093/nar/gkl971 – ident: 949_CR42 doi: 10.1038/s41598-021-90868-2 – volume: 41 start-page: 450 issue: 3 year: 2017 ident: 949_CR5 publication-title: FEMS Microbiology Reviews doi: 10.1093/femsre/fux016 – volume: 11 start-page: 256 year: 2020 ident: 949_CR9 publication-title: Frontiers in Microbiology doi: 10.3389/fmicb.2020.00256 – volume: 6 start-page: 267 issue: 5 year: 2016 ident: 949_CR21 publication-title: Annals of Medical and Health Sciences Research doi: 10.4103/amhsr.amhsr_413_15 – volume: 32 start-page: 2319 issue: 10 year: 2011 ident: 949_CR61 publication-title: Journal of Computational Chemistry doi: 10.1002/jcc.21787 – volume: 14 start-page: 1 issue: 1 year: 2013 ident: 949_CR51 publication-title: BMC Bioinformatics doi: 10.1186/1471-2105-14-S19-S1 – volume: 17 issue: 1 year: 2022 ident: 949_CR75 publication-title: PLoS One – volume: 28 start-page: 1071 issue: 9 year: 2020 ident: 949_CR54 publication-title: Structure doi: 10.1016/j.str.2020.06.006 – volume: 31 issue: 12 year: 2022 ident: 949_CR50 publication-title: Protein Science doi: 10.1002/pro.4473 – volume: 21 start-page: 605 issue: 7–8 year: 2003 ident: 949_CR15 publication-title: Vaccine doi: 10.1016/S0264-410X(02)00566-2 – ident: 949_CR28 doi: 10.3390/ijerph19063729 – volume: 196 start-page: 167 issue: 2 year: 2019 ident: 949_CR66 publication-title: Clinical and Experimental Immunology doi: 10.1111/cei.13292 – volume: 44 start-page: D663 issue: D1 year: 2016 ident: 949_CR36 publication-title: Nucleic Acids Research doi: 10.1093/nar/gkv1271 – volume: 33 start-page: W72 issue: suppl 2 year: 2005 ident: 949_CR49 publication-title: Nucleic Acids Research doi: 10.1093/nar/gki396 – ident: 949_CR26 doi: 10.3390/ijerph19095568 – volume: 35 start-page: 4064 issue: 33 year: 2017 ident: 949_CR11 publication-title: Vaccine doi: 10.1016/j.vaccine.2017.06.003 – volume: 146 year: 2020 ident: 949_CR31 publication-title: European Journal of Pharmaceutical Sciences doi: 10.1016/j.ejps.2020.105258 – volume: 6 start-page: 392 year: 2015 ident: 949_CR7 publication-title: Frontiers in Microbiology doi: 10.3389/fmicb.2015.00392 – volume: 20 start-page: 32 issue: 7–8 year: 2002 ident: 949_CR14 publication-title: Chimica Oggi – volume: 6 start-page: 255 issue: 7 year: 2011 ident: 949_CR77 publication-title: Bioinformation doi: 10.6026/97320630006255 – volume: 72 start-page: 741 year: 2016 ident: 949_CR8 publication-title: Microbial Ecology doi: 10.1007/s00248-015-0720-6 – ident: 949_CR47 doi: 10.1093/nar/gku938 – volume: 360 start-page: 631 issue: 6 year: 2020 ident: 949_CR4 publication-title: The American Journal of the Medical Sciences doi: 10.1016/j.amjms.2020.06.028 – ident: 949_CR60 doi: 10.1007/978-1-61779-588-6_10 – ident: 949_CR24 doi: 10.3390/vaccines10020189 – ident: 949_CR46 doi: 10.1371/journal.pone.0286224 – ident: 949_CR38 doi: 10.1093/nar/gkab279 – volume-title: Basic local alignment search tool year: 2015 ident: 949_CR41 – ident: 949_CR63 doi: 10.1016/j.ejps.2020.105387 – ident: 949_CR29 doi: 10.3390/ijerph19137723 – volume: 14 start-page: 859 issue: 12 year: 2003 ident: 949_CR37 publication-title: Mammalian Genome doi: 10.1007/s00335-003-2296-6 – ident: 949_CR43 doi: 10.1093/nar/gky1006 – volume: 35 start-page: D61 issue: suppl 1 year: 2007 ident: 949_CR68 publication-title: Nucleic Acids Research doi: 10.1093/nar/gkl842 – volume: 13 year: 2022 ident: 949_CR76 publication-title: Frontiers in Immunology doi: 10.3389/fimmu.2022.1042997 – volume: 84 year: 2023 ident: 949_CR74 publication-title: Brazilian Journal of Biology – start-page: W24 volume-title: Nucleic acids research year: 2017 ident: 949_CR45 – volume: 125 start-page: S3 issue: 2 year: 2010 ident: 949_CR69 publication-title: Journal of Allergy and Clinical Immunology doi: 10.1016/j.jaci.2009.12.980 – ident: 949_CR57 doi: 10.1007/978-1-59745-177-2_4 – volume: 25 start-page: 1034 issue: 6 year: 2020 ident: 949_CR13 publication-title: Drug Discovery Today doi: 10.1016/j.drudis.2020.03.006 – ident: 949_CR27 doi: 10.3390/vaccines10111886 – ident: 949_CR40 – ident: 949_CR73 doi: 10.3390/vaccines10101729 – volume: 33 start-page: D501 issue: suppl 1 year: 2005 ident: 949_CR33 publication-title: Nucleic Acids Research – volume: 12 start-page: 190 issue: 2 year: 2002 ident: 949_CR55 publication-title: Current Opinion in Structural Biology doi: 10.1016/S0959-440X(02)00308-1 – ident: 949_CR71 doi: 10.1038/s41598-021-96863-x – volume: 10 start-page: 1310 issue: 10 year: 2021 ident: 949_CR1 publication-title: Pathogens doi: 10.3390/pathogens10101310 – ident: 949_CR48 doi: 10.3390/vaccines10050691 – volume: 5 issue: 4 year: 2010 ident: 949_CR64 publication-title: PLoS One – volume: 15 start-page: 182 issue: 2 year: 2018 ident: 949_CR19 publication-title: Cellular and Molecular Immunology doi: 10.1038/cmi.2017.92 – volume: 112 start-page: 3473 issue: 5 year: 2020 ident: 949_CR67 publication-title: Genomics doi: 10.1016/j.ygeno.2020.06.026 |
| SSID | ssj0021543 |
| Score | 2.5415416 |
| Snippet | Proteus penneri
(
P. penneri
) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological... Proteus penneri (P. penneri) is a bacillus-shaped, gram-negative, facultative anaerobe bacterium that is primarily an invasive pathogen and the etiological... |
| SourceID | proquest pubmed crossref springer |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 3498 |
| SubjectTerms | adjuvants Amino acids Amoxicillin Antibiotics B-lymphocytes Bacteria Binding energy Biochemistry Bioinformatics Biological Techniques Biotechnology Cell Biology Cephalosporins Chemistry Chemistry and Materials Science Cholera cholera toxin Cholera toxin B subunit computer simulation Core protein cross infection data collection energy Epitopes family Free energy Gene sequencing Genomes Genomic analysis Gibbs free energy Human Genetics Immune response Immune system immunoinformatics Internet Lymphocytes B Lymphocytes T macrolides Major histocompatibility complex Molecular dynamics Nosocomial infection Original Paper Oxacillin Pathogens Penicillin Protein Science Proteins proteome Proteomes Proteus penneri Strains (organisms) Superoxide dismutase T-lymphocytes Thermodynamics Toxins type VI secretion system vaccine development Vaccines Waterborne diseases |
| SummonAdditionalLinks | – databaseName: Biological Science Database dbid: M7P link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9QwEB_0VNAHP049q6dE8E2Dm6Qf6ZMsxx0Ksiz4wb2VtElkYa-t292D_e-dabpd5bh78akPSWFgvn5JZn4D8C4xSuVpInjmJprHJnbEAZnxOCBUgRm_n1ryNZvN9Pl5Ph8u3LqhrHIXE_tAbZuK7sg_KgqkMWWvT-1vTlOj6HV1GKFxG-4QS4LqS_fm44EL4UEosM8UTxFbDE0zoXVO0hQzzFiciutyvv03MV1Bm1deSvsEdPbof0V_DA8H6MmmwVaewC1XH8K9MIxyewgP_qImfAp2WrMvNfu2WKKpsL5Nl7sW3b91HftpKnqPZ6d15y7KpWOmtuxkpH4OnZ1s-sssEHyyWYMW0FygobM5sUJsOtZSeF8tnsGPs9PvJ5_5MJGBV_FEr7kRBk_MuY6F9on3LitLa5S0MpeyVK6K8wxVj58yxWUvlBPWJtZJZRGYeKmew0Hd1O4FMCmF8SLxGiN_jJGlrIgx2ftE-UmuqjICsVNHUQ105TQ1Y1nsiZZJhQWqsOhVWGwjeD_-0wayjht3H-_UVQyO2xV7XUXwdlxGl6N3FFO7ZtMVUmtq_021un6PQtuj0V9ZGsFRsKBRJIUxEXHgJIIPO5PaC3C9vC9vlvcV3JcIuEKpzTEcrFcb9xruVpfrRbd60zvGH1K3EUc priority: 102 providerName: ProQuest |
| Title | An In Silico Multi-epitopes Vaccine Ensemble and Characterization Against Nosocomial Proteus penneri |
| URI | https://link.springer.com/article/10.1007/s12033-023-00949-y https://www.ncbi.nlm.nih.gov/pubmed/37934390 https://www.proquest.com/docview/3128449015 https://www.proquest.com/docview/2886941683 https://www.proquest.com/docview/3154172876 |
| Volume | 66 |
| WOSCitedRecordID | wos001100398000003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAVX databaseName: Springer Nature - Connect here FIRST to enable access customDbUrl: eissn: 1559-0305 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0021543 issn: 1073-6085 databaseCode: RSV dateStart: 19970101 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED-xDQQ88FEYBEZlJN7AUm0nsfNYqk4gQVWtMPUtchIbVerSqmkn9b_nHCcpaAwJXhxFdqKT73z3s-4L4F2khUjiiFFpBoqGOjSuBqSkoUeoDC1-3bXki5xM1HyeTJuksKqNdm9dkrWmPiS7cdd3DG0MdeFwCd0fwQmaO-WO48XssrtmISjwYfVS0BgRRZMq8-d__G6ObmDMG_7R2uycP_4_gp_AowZmkqGXi6dwx5Q9uOcbT-57cH_U9nnrwcNfShI-g2JYks8lmS2WKCKkTs-lZo3Hfm0qcqlz54cn47IyV9nSEF0WZNSVfPYZnWT4Qy8QdJLJCjm_ukIBJ1NXDWJXkbVT65vFc_h-Pv42-kSbTgw0DwdqSzXTeFNOVMiUjaw1MssKLXjBE84zYfIwkchyfGQxTlsmDCuKqDBcFMghy8UpHJer0rwEwjnTlkVWocYPUaNkuauUbG0k7CAReRYAaxmS5k2ZctctY5keCiy7fU1xX9N6X9N9AO-7b9a-SMdfV5-1fE6bA1ulwtnp0IGjAN5208gJ5z_RpVntqpQr5dJ-YyVuXyNQ-lzLLxkH8MLLUEeSQF2I-G8QwIdWYA4E3E7vq39b_hoecARePuTmDI63m515A3fz6-2i2vThSM5lPao-nHwcT6YX-PaVT90o_Tjr1wfqJ91vEi4 |
| linkProvider | Springer Nature |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Nb9NAEB1VBQQc-ChfhgKLBCdYkd31x_qAUFRaNWqIIlFQb-7a3kWRUtvECSh_it_IrNd2QFV764FTDralSfz2zdvszBuA14ESIg4DRiM9kNRXvrYekBH1nUJlmPGbqSXjaDKRJyfxdAt-d70wtqyy48SGqPMys_-RvxeWSH2bvT5WP6idGmVPV7sRGg4WR3r9C7ds9YfRJ3y_bzg_2D_eO6TtVAGa-QO5pIop3PXF0mfSBMboKE1zJXjOY85ToTM_jjB8_EhDvGyY0CzPg1xzkWNyNdboACn_GsoILptSwWm_wUM54gr6I0FD1DJtk45r1eN2ahpmSGqL-WK6_jcRnlO3505mm4R3cPd_-6nuwZ1WWpOhWwv3YUsXO3DDDdtc78Dtv6wXH0A-LMioIF9mc1wKpGlDprpCeqt0Tb6pzNYbkP2i1mfpXBNV5GSvt7Z2natk-F3NUFyTSYkIL89wIZOpdb1Y1aSy6Wsxewhfr-QLP4Ltoiz0EyCcM2VYYCRmNh-ZM82sI7QxgTCDWGSpB6x7_UnW2rHbqSDzZGMkbSGTIGSSBjLJ2oO3_TOVMyO59O7dDh5JS0x1ssGGB6_6y0gp9pxIFbpc1QmX0rY3h1JcfI9ArNvRZlHowWOH2D4kgZyPOnfgwbsOwpsALo736eXxvoSbh8efx8l4NDl6Brc4iktXVrQL28vFSj-H69nP5axevGgWJYHTq4b2HxeQb0k |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5V5SE48ChQAgWMBCewurHzPCC0arti1Wq1Eg_1FpzERittk3SzC9q_xq9jJk6yoKq99cApByeSnXwz3zie-Qbgja-kjAPf5aEeRNxTniYNyJB7NkJ1kfGbriUn4WQSnZ7G0y343dXCUFpl5xMbR52XGf0j35fkSD1ir33TpkVMD0cfq3NOHaTopLVrp2EhcqzXv3D7Vn8YH-K3fivE6OjLwSfedhjgmTeIlly5CneAceS5kfGN0WGa5kqKXMRCpFJnXhziUvCSBjhsXKndPPdzLWSORGtI9ADd_42QRMubtMFpv9nD0MQm94eSBxjXtAU7tmxPUAc1ZEtOiX0xX_9Lihci3QuntA35je7_z6_tAdxrQ242tDbyELZ0sQO3bBPO9Q7c_UuS8RHkw4KNC_Z5NkcTYU15MtcVur1K1-ybyigPgR0VtT5L55qpImcHveS1rWhlwx9qhkE3m5SI_PIMDZxNSQ1jVbOKaG0xewxfr2XBT2C7KAv9FJgQrjKubyJkPA89apqRUrQxvjSDWGapA24HhSRrZdqpW8g82QhME3wShE_SwCdZO_Cuf6ayIiVX3r3XQSVpHVadbHDiwOt-GF0NnR-pQperOhFRRGXPQSQvv0ci7qnlWRg4sGvR209JIhdg_Dtw4H0H580ELp_vs6vn-wpuI6KTk_Hk-DncERhz2myjPdheLlb6BdzMfi5n9eJlY58Mvl83sv8ARaZ4Bg |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=An+In+Silico+Multi-epitopes+Vaccine+Ensemble+and+Characterization+Against+Nosocomial+Proteus+penneri&rft.jtitle=Molecular+biotechnology&rft.au=Ullah%2C+Asad&rft.au=Rehman%2C+Bushra&rft.au=Khan%2C+Saifullah&rft.au=Almanaa%2C+Taghreed+N.&rft.date=2024-12-01&rft.issn=1073-6085&rft.eissn=1559-0305&rft.volume=66&rft.issue=12&rft.spage=3498&rft.epage=3513&rft_id=info:doi/10.1007%2Fs12033-023-00949-y&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_s12033_023_00949_y |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-6085&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-6085&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-6085&client=summon |